Targeted Mass Spectrometry Enables Multiplexed Quantification of Immunomodulatory Proteins in Clinical Biospecimens
Immunotherapies are revolutionizing cancer care, producing durable responses and potentially cures in a subset of patients. However, response rates are low for most tumors, grade 3/4 toxicities are not uncommon, and our current understanding of tumor immunobiology is incomplete. While hundreds of im...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2231b7f4bf4c4dfdac9a7d21bf8f78b2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:2231b7f4bf4c4dfdac9a7d21bf8f78b2 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:2231b7f4bf4c4dfdac9a7d21bf8f78b22021-11-11T08:45:18ZTargeted Mass Spectrometry Enables Multiplexed Quantification of Immunomodulatory Proteins in Clinical Biospecimens1664-322410.3389/fimmu.2021.765898https://doaj.org/article/2231b7f4bf4c4dfdac9a7d21bf8f78b22021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fimmu.2021.765898/fullhttps://doaj.org/toc/1664-3224Immunotherapies are revolutionizing cancer care, producing durable responses and potentially cures in a subset of patients. However, response rates are low for most tumors, grade 3/4 toxicities are not uncommon, and our current understanding of tumor immunobiology is incomplete. While hundreds of immunomodulatory proteins in the tumor microenvironment shape the anti-tumor response, few of them can be reliably quantified. To address this need, we developed a multiplex panel of targeted proteomic assays targeting 52 peptides representing 46 proteins using peptide immunoaffinity enrichment coupled to multiple reaction monitoring-mass spectrometry. We validated the assays in tissue and plasma matrices, where performance figures of merit showed over 3 orders of dynamic range and median inter-day CVs of 5.2% (tissue) and 21% (plasma). A feasibility study in clinical biospecimens showed detection of 48/52 peptides in frozen tissue and 38/52 peptides in plasma. The assays are publicly available as a resource for the research community.Jeffrey R. WhiteakerRachel A. LundeenLei ZhaoRegine M. SchoenherrAura BurianDongqing HuangUlianna VoytovichTao WangJacob J. KennedyRichard G. IveyChenwei LinOscar D. MurilloTravis D. LorentzenMathangi ThiagarajanSimona ColantonioTessa W. CaceresRhonda R. RobertsJoseph G. KnottsJoshua J. ReadingJan A. KaczmarczykChristopher W. RichardsonSandra S. Garcia-BuntleyWilliam BocikStephen M. HewittKaren E. MurrayNhan DoNhan DoMary BrophyMary BrophyStephen W. WilzStephen W. WilzHongbo YuHongbo YuSamuel AjjarapuSamuel AjjarapuEmily BojaTara HiltkeHenry RodriguezAmanda G. PaulovichFrontiers Media S.A.articleimmunotherapycancercorrelative biomarkersmass spectrometryimmuno-MRMImmunologic diseases. AllergyRC581-607ENFrontiers in Immunology, Vol 12 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
immunotherapy cancer correlative biomarkers mass spectrometry immuno-MRM Immunologic diseases. Allergy RC581-607 |
spellingShingle |
immunotherapy cancer correlative biomarkers mass spectrometry immuno-MRM Immunologic diseases. Allergy RC581-607 Jeffrey R. Whiteaker Rachel A. Lundeen Lei Zhao Regine M. Schoenherr Aura Burian Dongqing Huang Ulianna Voytovich Tao Wang Jacob J. Kennedy Richard G. Ivey Chenwei Lin Oscar D. Murillo Travis D. Lorentzen Mathangi Thiagarajan Simona Colantonio Tessa W. Caceres Rhonda R. Roberts Joseph G. Knotts Joshua J. Reading Jan A. Kaczmarczyk Christopher W. Richardson Sandra S. Garcia-Buntley William Bocik Stephen M. Hewitt Karen E. Murray Nhan Do Nhan Do Mary Brophy Mary Brophy Stephen W. Wilz Stephen W. Wilz Hongbo Yu Hongbo Yu Samuel Ajjarapu Samuel Ajjarapu Emily Boja Tara Hiltke Henry Rodriguez Amanda G. Paulovich Targeted Mass Spectrometry Enables Multiplexed Quantification of Immunomodulatory Proteins in Clinical Biospecimens |
description |
Immunotherapies are revolutionizing cancer care, producing durable responses and potentially cures in a subset of patients. However, response rates are low for most tumors, grade 3/4 toxicities are not uncommon, and our current understanding of tumor immunobiology is incomplete. While hundreds of immunomodulatory proteins in the tumor microenvironment shape the anti-tumor response, few of them can be reliably quantified. To address this need, we developed a multiplex panel of targeted proteomic assays targeting 52 peptides representing 46 proteins using peptide immunoaffinity enrichment coupled to multiple reaction monitoring-mass spectrometry. We validated the assays in tissue and plasma matrices, where performance figures of merit showed over 3 orders of dynamic range and median inter-day CVs of 5.2% (tissue) and 21% (plasma). A feasibility study in clinical biospecimens showed detection of 48/52 peptides in frozen tissue and 38/52 peptides in plasma. The assays are publicly available as a resource for the research community. |
format |
article |
author |
Jeffrey R. Whiteaker Rachel A. Lundeen Lei Zhao Regine M. Schoenherr Aura Burian Dongqing Huang Ulianna Voytovich Tao Wang Jacob J. Kennedy Richard G. Ivey Chenwei Lin Oscar D. Murillo Travis D. Lorentzen Mathangi Thiagarajan Simona Colantonio Tessa W. Caceres Rhonda R. Roberts Joseph G. Knotts Joshua J. Reading Jan A. Kaczmarczyk Christopher W. Richardson Sandra S. Garcia-Buntley William Bocik Stephen M. Hewitt Karen E. Murray Nhan Do Nhan Do Mary Brophy Mary Brophy Stephen W. Wilz Stephen W. Wilz Hongbo Yu Hongbo Yu Samuel Ajjarapu Samuel Ajjarapu Emily Boja Tara Hiltke Henry Rodriguez Amanda G. Paulovich |
author_facet |
Jeffrey R. Whiteaker Rachel A. Lundeen Lei Zhao Regine M. Schoenherr Aura Burian Dongqing Huang Ulianna Voytovich Tao Wang Jacob J. Kennedy Richard G. Ivey Chenwei Lin Oscar D. Murillo Travis D. Lorentzen Mathangi Thiagarajan Simona Colantonio Tessa W. Caceres Rhonda R. Roberts Joseph G. Knotts Joshua J. Reading Jan A. Kaczmarczyk Christopher W. Richardson Sandra S. Garcia-Buntley William Bocik Stephen M. Hewitt Karen E. Murray Nhan Do Nhan Do Mary Brophy Mary Brophy Stephen W. Wilz Stephen W. Wilz Hongbo Yu Hongbo Yu Samuel Ajjarapu Samuel Ajjarapu Emily Boja Tara Hiltke Henry Rodriguez Amanda G. Paulovich |
author_sort |
Jeffrey R. Whiteaker |
title |
Targeted Mass Spectrometry Enables Multiplexed Quantification of Immunomodulatory Proteins in Clinical Biospecimens |
title_short |
Targeted Mass Spectrometry Enables Multiplexed Quantification of Immunomodulatory Proteins in Clinical Biospecimens |
title_full |
Targeted Mass Spectrometry Enables Multiplexed Quantification of Immunomodulatory Proteins in Clinical Biospecimens |
title_fullStr |
Targeted Mass Spectrometry Enables Multiplexed Quantification of Immunomodulatory Proteins in Clinical Biospecimens |
title_full_unstemmed |
Targeted Mass Spectrometry Enables Multiplexed Quantification of Immunomodulatory Proteins in Clinical Biospecimens |
title_sort |
targeted mass spectrometry enables multiplexed quantification of immunomodulatory proteins in clinical biospecimens |
publisher |
Frontiers Media S.A. |
publishDate |
2021 |
url |
https://doaj.org/article/2231b7f4bf4c4dfdac9a7d21bf8f78b2 |
work_keys_str_mv |
AT jeffreyrwhiteaker targetedmassspectrometryenablesmultiplexedquantificationofimmunomodulatoryproteinsinclinicalbiospecimens AT rachelalundeen targetedmassspectrometryenablesmultiplexedquantificationofimmunomodulatoryproteinsinclinicalbiospecimens AT leizhao targetedmassspectrometryenablesmultiplexedquantificationofimmunomodulatoryproteinsinclinicalbiospecimens AT reginemschoenherr targetedmassspectrometryenablesmultiplexedquantificationofimmunomodulatoryproteinsinclinicalbiospecimens AT auraburian targetedmassspectrometryenablesmultiplexedquantificationofimmunomodulatoryproteinsinclinicalbiospecimens AT dongqinghuang targetedmassspectrometryenablesmultiplexedquantificationofimmunomodulatoryproteinsinclinicalbiospecimens AT uliannavoytovich targetedmassspectrometryenablesmultiplexedquantificationofimmunomodulatoryproteinsinclinicalbiospecimens AT taowang targetedmassspectrometryenablesmultiplexedquantificationofimmunomodulatoryproteinsinclinicalbiospecimens AT jacobjkennedy targetedmassspectrometryenablesmultiplexedquantificationofimmunomodulatoryproteinsinclinicalbiospecimens AT richardgivey targetedmassspectrometryenablesmultiplexedquantificationofimmunomodulatoryproteinsinclinicalbiospecimens AT chenweilin targetedmassspectrometryenablesmultiplexedquantificationofimmunomodulatoryproteinsinclinicalbiospecimens AT oscardmurillo targetedmassspectrometryenablesmultiplexedquantificationofimmunomodulatoryproteinsinclinicalbiospecimens AT travisdlorentzen targetedmassspectrometryenablesmultiplexedquantificationofimmunomodulatoryproteinsinclinicalbiospecimens AT mathangithiagarajan targetedmassspectrometryenablesmultiplexedquantificationofimmunomodulatoryproteinsinclinicalbiospecimens AT simonacolantonio targetedmassspectrometryenablesmultiplexedquantificationofimmunomodulatoryproteinsinclinicalbiospecimens AT tessawcaceres targetedmassspectrometryenablesmultiplexedquantificationofimmunomodulatoryproteinsinclinicalbiospecimens AT rhondarroberts targetedmassspectrometryenablesmultiplexedquantificationofimmunomodulatoryproteinsinclinicalbiospecimens AT josephgknotts targetedmassspectrometryenablesmultiplexedquantificationofimmunomodulatoryproteinsinclinicalbiospecimens AT joshuajreading targetedmassspectrometryenablesmultiplexedquantificationofimmunomodulatoryproteinsinclinicalbiospecimens AT janakaczmarczyk targetedmassspectrometryenablesmultiplexedquantificationofimmunomodulatoryproteinsinclinicalbiospecimens AT christopherwrichardson targetedmassspectrometryenablesmultiplexedquantificationofimmunomodulatoryproteinsinclinicalbiospecimens AT sandrasgarciabuntley targetedmassspectrometryenablesmultiplexedquantificationofimmunomodulatoryproteinsinclinicalbiospecimens AT williambocik targetedmassspectrometryenablesmultiplexedquantificationofimmunomodulatoryproteinsinclinicalbiospecimens AT stephenmhewitt targetedmassspectrometryenablesmultiplexedquantificationofimmunomodulatoryproteinsinclinicalbiospecimens AT karenemurray targetedmassspectrometryenablesmultiplexedquantificationofimmunomodulatoryproteinsinclinicalbiospecimens AT nhando targetedmassspectrometryenablesmultiplexedquantificationofimmunomodulatoryproteinsinclinicalbiospecimens AT nhando targetedmassspectrometryenablesmultiplexedquantificationofimmunomodulatoryproteinsinclinicalbiospecimens AT marybrophy targetedmassspectrometryenablesmultiplexedquantificationofimmunomodulatoryproteinsinclinicalbiospecimens AT marybrophy targetedmassspectrometryenablesmultiplexedquantificationofimmunomodulatoryproteinsinclinicalbiospecimens AT stephenwwilz targetedmassspectrometryenablesmultiplexedquantificationofimmunomodulatoryproteinsinclinicalbiospecimens AT stephenwwilz targetedmassspectrometryenablesmultiplexedquantificationofimmunomodulatoryproteinsinclinicalbiospecimens AT hongboyu targetedmassspectrometryenablesmultiplexedquantificationofimmunomodulatoryproteinsinclinicalbiospecimens AT hongboyu targetedmassspectrometryenablesmultiplexedquantificationofimmunomodulatoryproteinsinclinicalbiospecimens AT samuelajjarapu targetedmassspectrometryenablesmultiplexedquantificationofimmunomodulatoryproteinsinclinicalbiospecimens AT samuelajjarapu targetedmassspectrometryenablesmultiplexedquantificationofimmunomodulatoryproteinsinclinicalbiospecimens AT emilyboja targetedmassspectrometryenablesmultiplexedquantificationofimmunomodulatoryproteinsinclinicalbiospecimens AT tarahiltke targetedmassspectrometryenablesmultiplexedquantificationofimmunomodulatoryproteinsinclinicalbiospecimens AT henryrodriguez targetedmassspectrometryenablesmultiplexedquantificationofimmunomodulatoryproteinsinclinicalbiospecimens AT amandagpaulovich targetedmassspectrometryenablesmultiplexedquantificationofimmunomodulatoryproteinsinclinicalbiospecimens |
_version_ |
1718439290701086720 |